Adipose extracellular vesicle CFD in growth hormone–driven insulin-dependent hepatic steatosis

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, but how adipose tissue dysfunction drives hepatic steatosis remains unclear. Hepatic growth hormone (GH) resistance causes marked lipid accumulation, yet the contribution of adipose GH signaling is unknown. Here we show that adipose tissue–derived complement factor D (CFD) mediates hepatic steatosis in mice with liver-specific GH receptor ( Ghr ) deficiency by comparing liver-specific Ghr knockout mice ( L-Ghr −/− ) with mice lacking Ghr in both liver and adipose tissue. Cfd knockout protects against diet-induced obesity-associated steatosis and reduces steatosis in L-Ghr −/− mice, identifying CFD as a circulating driver of hepatic steatosis. Mechanistically, Adipose GH signaling promotes PPARγ–STAT5B-dependent Cfd transcription, and CFD is packaged into extracellular vesicles that enhance β-cell insulin secretion, promoting hepatic lipogenesis. Inhibiting CFD or its vesicular delivery alleviates steatosis in mice, and circulating vesicle-associated CFD correlates with disease severity in patients with MASLD.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11624174/v1
Primary Topic
Liver Disease Diagnosis and Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Adipose extracellular vesicle CFD in growth hormone–driven insulin-dependent hepatic steatosis

Fei Gao, Chuang Liu, Junliang Chen, Rui Zhao et al.
Research Square
Liver Disease Diagnosis and Treatment
preprint

Adipose extracellular vesicle CFD in growth hormone–driven insulin-dependent hepatic steatosis

Fei Gao, Chuang Liu, Junliang Chen, Rui Zhao, Fei Fang, Kejian Wei, Xu Chengying, Longlong Wang, Peng Wei, Yingjie Zhang, Guocai Duan, Tong Wu, Yajie Wang, Zhonghua Lu, Tao Wan
preprint en

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, but how adipose tissue dysfunction drives hepatic steatosis remains unclear. Hepatic growth hormone (GH) resistance causes marked lipid accumulation, yet the contribution of adipose GH signaling is unknown. Here we show that adipose tissue–derived complement factor D (CFD) mediates hepatic steatosis in mice with liver-specific GH receptor ( Ghr ) deficiency by comparing liver-specific Ghr knockout mice ( L-Ghr −/− ) with mice lacking Ghr in both liver and adipose tissue. Cfd knockout protects against diet-induced obesity-associated steatosis and reduces steatosis in L-Ghr −/− mice, identifying CFD as a circulating driver of hepatic steatosis. Mechanistically, Adipose GH signaling promotes PPARγ–STAT5B-dependent Cfd transcription, and CFD is packaged into extracellular vesicles that enhance β-cell insulin secretion, promoting hepatic lipogenesis. Inhibiting CFD or its vesicular delivery alleviates steatosis in mice, and circulating vesicle-associated CFD correlates with disease severity in patients with MASLD.

Research Square
Jiangnan University (CN), Guangdong University of Technology (CN), Affiliated Hospital of Nantong University (CN)
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon